Generate a tailored SOP for Dr. Theresa Shireman. Improve your application with a focused, well-structured draft.
Theresa Shireman is a health services researcher specializing in pharmaceutical policy and pharmacoepidemiology, with a focus on health economic evaluations. Her significant research contributions include enhancing the understanding of medications used to affect people on chronic dialysis and developing novel methodologies for tracking medication exposure over time. She has created a bleeding risk prediction model for older adult patients on warfarin and conducted extensive health economic evaluations of expensive therapeutic agents. Additionally, Dr. Shireman has managed numerous contracts with State Medicaid agencies to evaluate pharmaceutical use among children with disabilities and other vulnerable populations, investigating the quality of diabetes care for individuals with disabilities. Her ongoing research projects include evaluating the impact of Medicaid prescription cap policies on adherence and costs for individuals living with HIV, as well as examining federal initiatives aimed at reducing antipsychotic use among nursing home residents and assessing quality care outcomes for insured transgender populations. She teaches graduate courses and mentors graduate students and post-doctoral fellows.
Department: Department of Economics